Title:
HETEROCYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2016/158956
Kind Code:
A1
Abstract:
Provided is a compound having an MAGL inhibitory effect, and expected to be useful as an agent for the prevention or treatment of neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, Hutchinson's disease, amyotrophic lateral sclerosis, traumatic brain injury, glaucoma, multiple sclerosis, etc.), anxiety disorders, pain (e.g., inflammatory pain, cancer pain, neuropathic pain, etc.), epilepsy, depression, and the like. The present invention pertains to a compound represented by formula (I): (symbols in the formula are as described in the description) or a salt thereof.
Inventors:
IKEDA SHUHEI (JP)
KOIKE TATSUKI (JP)
AIDA JUMPEI (JP)
FUSHIMI MAKOTO (JP)
KUSUMOTO TOMOKAZU (JP)
SUGIYAMA HIDEYUKI (JP)
MIYAZAKI MASAKO (JP)
TOKUHARA HIDEKAZU (JP)
HATTORI YASUSHI (JP)
KAMATA MAKOTO (JP)
KOIKE TATSUKI (JP)
AIDA JUMPEI (JP)
FUSHIMI MAKOTO (JP)
KUSUMOTO TOMOKAZU (JP)
SUGIYAMA HIDEYUKI (JP)
MIYAZAKI MASAKO (JP)
TOKUHARA HIDEKAZU (JP)
HATTORI YASUSHI (JP)
KAMATA MAKOTO (JP)
Application Number:
PCT/JP2016/060134
Publication Date:
October 06, 2016
Filing Date:
March 29, 2016
Export Citation:
Assignee:
TAKEDA PHARMACEUTICALS CO (JP)
International Classes:
C07D401/06; A61K31/454; A61K31/4709; A61K31/538; A61K31/5383; A61P25/04; A61P25/08; A61P25/16; A61P25/28; A61P43/00; C07D413/06; C07D413/14; C07D417/14; C07D471/04; C07D498/04; C12N9/99
Domestic Patent References:
| WO2001064676A2 | 2001-09-07 | |||
| WO2011058766A1 | 2011-05-19 |
Foreign References:
| JP2012524810A | 2012-10-18 | |||
| JP2012524800A | 2012-10-18 | |||
| JP2013536852A | 2013-09-26 |
Other References:
See also references of EP 3279191A4
Attorney, Agent or Firm:
TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)
Takashima 1 (JP)
Download PDF: